Significant growth in demand for pharmaceuticals, such as GLP-1s, increased R&D spending for autonomous manufacturing, and the increased presence of contract manufacturers globally are among the key ...

Halo Pharmaceutical is a privately owned full service FDA, BLA and DEA (Schedule II-V) compliant CDMO, headquartered in ...

BioPlan Associates presents research and projections on the pharma sterile fill-finish industry’s future over the next 10 years.

This link in the pharma supply chain is undergoing a major transformation propelled by technological advancements, regulatory changes, and evolving market dynamics, requiring industry leaders to adopt ...

Access to specialised expertise and technologies Biologics manufacturing often requires highly specialised knowledge, equipment, and facilities that can be challenging for pharmaceutical companies ...

Following big announcements from Lilly and Merck, J&J is pledging $55 billion over the next four years to open new plants.

The investment of over $6 million will expand LGM Pharma’s Rosenberg, Texas manufacturing facility as part of its Phase I ...

Contract Development and Manufacturing Organizations (CDMOs) enhance drug discovery by providing essential services that ...

Artificial intelligence (AI) and the Internet of Things (IoT) are about to revolutionize the biopharmaceutical industry.

With over 15 years of expertise in developing injectable and liquid pharmaceutical forms, CARBOGEN AMCIS’ Saint-Beauzire site provides tailored solutions for pre-clinical and clinical trials and small ...

Feb. 26 (UPI) --Eli Lilly announced plans for four new pharmaceutical manufacturing sites to produce domestic medicine production in the United States and make the nation the world's leader in ...